| HIF-1α is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of Tregs in glioblastoma J Miska, C Lee-Chang, A Rashidi, ME Muroski, AL Chang, ... Cell Reports 27 (1), 226-237. e4, 2019 | 294 | 2019 |
| Immunosuppressive and prometastatic functions of myeloid-derived suppressive cells rely upon education from tumor-associated B cells M Bodogai, K Moritoh, C Lee-Chang, CM Hollander, CA Sherman-Baust, ... Cancer research 75 (17), 3456-3465, 2015 | 176 | 2015 |
| Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells M Bodogai, J O’Connell, K Kim, Y Kim, K Moritoh, C Chen, F Gusev, ... Science translational medicine 10 (467), eaat4271, 2018 | 169 | 2018 |
| Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells C Lee-Chang, M Bodogai, A Martin-Montalvo, K Wejksza, M Sanghvi, ... The Journal of Immunology 191 (8), 4141-4151, 2013 | 167 | 2013 |
| Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial J Fares, AU Ahmed, IV Ulasov, AM Sonabend, J Miska, C Lee-Chang, ... The Lancet Oncology 22 (8), 1103-1114, 2021 | 145 | 2021 |
| Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma P Zhang, J Miska, C Lee-Chang, A Rashidi, WK Panek, S An, M Zannikou, ... Proceedings of the National Academy of Sciences 116 (47), 23714-23723, 2019 | 144 | 2019 |
| Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L M Bodogai, C Lee Chang, K Wejksza, J Lai, M Merino, RP Wersto, ... Cancer research 73 (7), 2127-2138, 2013 | 141 | 2013 |
| Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment VA Arrieta, C Dmello, DJ McGrail, DJ Brat, C Lee-Chang, AB Heimberger, ... The Journal of Clinical Investigation 133 (2), 2023 | 130 | 2023 |
| Myeloid-derived suppressive cells promote B cell–mediated immunosuppression via transfer of PD-L1 in glioblastoma C Lee-Chang, A Rashidi, J Miska, P Zhang, KC Pituch, D Hou, T Xiao, ... Cancer immunology research 7 (12), 1928-1943, 2019 | 130 | 2019 |
| The interplay between glioblastoma and its microenvironment M Dapash, D Hou, B Castro, C Lee-Chang, MS Lesniak Cells 10 (9), 2257, 2021 | 110 | 2021 |
| Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator–activated receptor α K Wejksza, C Lee-Chang, M Bodogai, J Bonzo, FJ Gonzalez, E Lehrmann, ... The Journal of Immunology 190 (6), 2575-2584, 2013 | 103 | 2013 |
| STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma P Zhang, A Rashidi, J Zhao, C Silvers, H Wang, B Castro, A Ellingwood, ... Nature communications 14 (1), 1610, 2023 | 95 | 2023 |
| ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma VA Arrieta, AX Chen, JR Kane, SJ Kang, C Kassab, C Dmello, J Zhao, ... Nature cancer 2 (12), 1372-1386, 2021 | 80 | 2021 |
| Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma J Miska, A Rashidi, C Lee-Chang, P Gao, A Lopez-Rosas, P Zhang, ... Science Advances 7 (8), eabc8929, 2021 | 74 | 2021 |
| Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment C Wu, ME Muroski, J Miska, C Lee-Chang, Y Shen, A Rashidi, P Zhang, ... Nanomedicine: Nanotechnology, Biology and Medicine 16, 126-137, 2019 | 57 | 2019 |
| Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma C Lee-Chang, J Miska, D Hou, A Rashidi, P Zhang, RA Burga, ... Journal of Experimental Medicine 218 (1), e20200913, 2020 | 53 | 2020 |
| Proinflammatory B-cell profile in the early phases of MS predicts an active disease T Guerrier, M Labalette, D Launay, C Lee-Chang, O Outteryck, G Lefèvre, ... Neurology: Neuroimmunology & Neuroinflammation 5 (2), e431, 2017 | 52 | 2017 |
| Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity C Lee-Chang, M Bodogai, K Moritoh, PB Olkhanud, AC Chan, M Croft, ... Blood, The Journal of the American Society of Hematology 124 (9), 1450-1459, 2014 | 51 | 2014 |
| GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma A Rashidi, J Miska, C Lee-Chang, D Kanojia, WK Panek, A Lopez-Rosas, ... Cancer Immunology, Immunotherapy 69, 81-94, 2020 | 45 | 2020 |
| IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM M Zannikou, JT Duffy, RN Levine, M Seblani, Q Liu, A Presser, VA Arrieta, ... Journal for immunotherapy of cancer 11 (2), 2023 | 41 | 2023 |
